A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis - a primary driver of cardiovascular death worldwide - in large mammals, a study suggests.

A research team led by Dr. Martin Mollenhauer from the Heart Center at University Hospital Cologne has investigated the link ...

Although the setup required to accomplish this feat is currently complicated, this finding could provide more understanding about how the brain perceives colour and could one day help boost the vision ...

Explore the complexities of Ulcerative Colitis, its causes, diagnostic methods, and breakthrough treatments for better ...

and nonalcoholic steatohepatitis (NASH), which is characterized by liver fat, inflammation and cell damage. An estimated 10 to 20 percent of Americans have NAFLD, while about two to five percent have ...

Through this meeting, Anjanette discovered that Mary Ann had end-stage liver disease. After learning she was a match, Anjanette became Mary Ann's liver donor. The mothers met transplant surgeon Dr.